EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition

Yuka Kawasaki, Kazuki Kakimoto, Yasuyoshi Tanaka, Hikaru Shimizu, Koji Nishida, Keijiro Numa, Naohiko Kinoshita, Yoshihiro Tatsumi, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota und 13 weitere

Digestion · 2023 · 104 (5) · 357-369

DOI: 10.1159/000528282 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Digestion, online erschienen am 11.05.2023. Verfasst von Yuka Kawasaki und 24 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Antineoplastic Agents. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim: Fluoropyrimidines (FPs) are key drugs in many chemotherapy regimens; however, recipients are often prone to diarrhea due to gastrointestinal toxicity. Disruption of the intestinal epithelial barrier function by FPs leads to dysbiosis, which may exacerbate intestinal epithelial cell damage as a secondary effect and trigger diarrhea. However, despite studies on chemotherapy-induced changes in the intestinal microbiome of humans, the relationship between dysbiosis and diarrhea is unclear. In this study, we aimed to investigate the relationship between chemotherapy-induced diarrhea and the intestinal microbiome.

Methods

We conducted a single-center prospective observational study. Twenty-three patients who received chemotherapy, including FPs as first-line chemotherapy for colorectal cancer, were included. Stool samples were collected before the start of chemotherapy and after one cycle of treatment to analyze intestinal microbiome composition and perform PICRUSt predictive metagenomic analysis.

Results

Gastrointestinal toxicity was observed in 7 of 23 patients (30.4%), diarrhea was observed in 4 (17.4%), and nausea and anorexia were observed in 3 (13.0%). In 19 patients treated with oral FPs, the α diversity of the microbial community decreased significantly following chemotherapy only in the diarrheal group. At the phylum level, the diarrheal group showed a significant decrease in the abundance of Firmicutes and a significant increase in the abundance of Bacteroidetes with chemotherapy (p = 0.013 and 0.011, respectively). In the same groups, at the genus level, Bifidobacterium abundance was significantly decreased (p = 0.019). In contrast, in the non-diarrheal group, Actinobacteria abundance increased significantly with chemotherapy at the phylum level (p = 0.011). Further, Bifidobacterium, Fusicatenibacter, and Dorea abundance significantly increased at the genus level (p = 0.006, 0.019, and 0.011, respectively). The PICRUSt predictive metagenomic analysis revealed that chemotherapy caused significant differences in membrane transport in KEGG pathway level 2 and in 8 KEGG pathway level 3, including transporters and oxidative phosphorylation in the diarrhea group.

Conclusion

Organic-acid-producing bacteria seem to be involved in diarrhea associated with chemotherapy, including FPs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAntineoplastic AgentsHumansDysbiosisDiarrheaBacteriaRNA, Ribosomal, 16S

Stichwörter der Autor:innen

ChemotherapyDiarrheaFluoropyrimidinesIntestinal microbiome

Substanzen

Antineoplastic AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • 2nd Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • R&D Center, Biofermin Pharmaceutical Co., Ltd., Kobe, Japan.

Zitieren

APA

Kawasaki, Y., Kakimoto, K., Tanaka, Y., Shimizu, H., Nishida, K., Numa, K., Kinoshita, N., Tatsumi, Y., Nakazawa, K., Koshiba, R., Hirata, Y., Ota, K., Sakiyama, N., Terazawa, T., Takeuchi, T., Miyazaki, T., Goto, M., Yokota, H., Makizaki, Y., …, & Nishikawa, H. (2023). Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition. Digestion, 104(5), 357-369. https://doi.org/10.1159/000528282

Vancouver

Kawasaki Y, Kakimoto K, Tanaka Y, Shimizu H, Nishida K, Numa K, et al. Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition. Digestion. 2023;104(5):357-369. doi:10.1159/000528282

BibTeX
@article{Kawasaki2023,
  author = {Kawasaki, Yuka and Kakimoto, Kazuki and Tanaka, Yasuyoshi and Shimizu, Hikaru and Nishida, Koji and Numa, Keijiro and Kinoshita, Naohiko and Tatsumi, Yoshihiro and Nakazawa, Kei and Koshiba, Ryoji and Hirata, Yuki and Ota, Kazuhiro and Sakiyama, Naokuni and Terazawa, Tetsuji and Takeuchi, Toshihisa and Miyazaki, Takako and Goto, Masahiro and Yokota, Haruka and Makizaki, Yutaka and Tanaka, Yoshiki and Nakajima, Shunji and Ohno, Hiroshi and Higuchi, Kazuhide and Nakamura, Shiro and Nishikawa, Hiroki},
  title = {Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition},
  journal = {Digestion},
  year = {2023},
  volume = {104},
  number = {5},
  pages = {357--369},
  doi = {10.1159/000528282}
}
Kostenlos starten →